Jpmorgan Chase & CO Lucid Diagnostics Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding LUCD
# of Institutions
37Shares Held
3.87MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.02MShares$1.33 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$734,7980.0% of portfolio
-
Sargent Investment Group, LLC542KShares$709,3650.07% of portfolio
-
Sunbelt Securities, Inc. Houston, TX384KShares$503,0380.06% of portfolio
-
Geode Capital Management, LLC Boston, MA280KShares$366,1500.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $50.5M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...